mhurhangee/patent-ind-claim-en huggingface dataset:
A computer-implemented method for positioning a table in a medical device, the table having a long direction, comprising: obtaining a target image including a subject situated on the table; determining a region of interest of the subject in the target image by segmenting the subject in the target image into a plurality of regions; designating a specific position in the region of interest in the target image; causing the target image to be displayed with a movable identifier on a terminal device, an initial position of the movable identifier corresponding to the specific position of the region of interest of the subject in the target image; obtaining, in the target image, a focus position within the region of interest of the subject, the focus position in the target image indicating a position and/or region of the region of interest to be scanned or treated by the medical device, wherein the obtaining the focus position includes: receiving a user instruction with respect to moving the movable identifier in the target image; and determining the focus position based on the movable identifier moved according to the user instruction; and determining, based on the focus position, a target table position, wherein when the table is at the target table position, the region of interest of the subject is located at an isocenter of the medical device. obtaining a target image including a subject situated on the table; determining a region of interest of the subject in the target image by segmenting the subject in the target image into a plurality of regions; designating a specific position in the region of interest in the target image; causing the target image to be displayed with a movable identifier on a terminal device, an initial position of the movable identifier corresponding to the specific position of the region of interest of the subject in the target image; obtaining, in the target image, a focus position within the region of interest of the subject, the focus position in the target image indicating a position and/or region of the region of interest to be scanned or treated by the medical device, wherein the obtaining the focus position includes: receiving a user instruction with respect to moving the movable identifier in the target image; and determining the focus position based on the movable identifier moved according to the user instruction; and receiving a user instruction with respect to moving the movable identifier in the target image; and determining the focus position based on the movable identifier moved according to the user instruction; and determining, based on the focus position, a target table position, wherein when the table is at the target table position, the region of interest of the subject is located at an isocenter of the medical device.
A preparation method of a flame-retardant polyester fiber, comprising performing an esterification reaction of terephthalic acid, unsaturated dibasic acid and ethylene glycol; after the esterification reaction, adding a flame retardant 2-carboxyethylphenyl phosphinic acid; obtaining the polyester by polycondensation under a catalysis of a mixture of magnesium ethylene glycol and antimony ethylene glycol; preparing the polyester sections after granulation; obtaining the flame-retardant polyester fiber by metering, extrusion, cooling, oiling, stretching, heat setting, winding and UV irradiation on the polyester sections; wherein the formula of magnesium ethylene glycol is Mg(OCH 2 CH 2 OH 2 ) 2 ; wherein in said mixture of magnesium glycol and antimony ethylene glycol, a mass ratio of magnesium ethylene glycol to antimony ethylene glycol is 2 to 3:1.
A control apparatus that is connected to a device for detecting a user's hand motion and controls a motion of a virtual character, the control apparatus comprising: a decision section adapted to decide, in accordance with a detection result of the user's hand motion by the device , whether the detected user's hand motion is a first instruction action that achieves a match between a hand motion of the character and the user's hand motion or a second instruction action that instructs an action different from the user's hand motion; and a character control section adapted to achieve a match between the character's hand motion and the detected user's hand motion when it is decided, as a result of the decision, that the detected user's hand motion is the first instruction action and adapted to cause the character to perform, on the basis of the detected user's hand motion, an action different from the user's hand motion when it is decided, as a result of the decision, that the detected user's hand motion is the second instruction action, characterized in that the device further includes a button to be pushed in in response to a user's action of clenching his or her fist; the control apparatus further includes a force sense presentation section adapted to present a force sense that resists the pushing in of the button; and in a case where the character performs an action of grasping a target in a virtual space and when an amount of pushing in of the button becomes equivalent to a size of the target, the character control section instructs the force sense presentation section to present a force sense that resists the pushing in of the button. a decision section adapted to decide, in accordance with a detection result of the user's hand motion by the device , whether the detected user's hand motion is a first instruction action that achieves a match between a hand motion of the character and the user's hand motion or a second instruction action that instructs an action different from the user's hand motion; and a character control section adapted to achieve a match between the character's hand motion and the detected user's hand motion when it is decided, as a result of the decision, that the detected user's hand motion is the first instruction action and adapted to cause the character to perform, on the basis of the detected user's hand motion, an action different from the user's hand motion when it is decided, as a result of the decision, that the detected user's hand motion is the second instruction action, characterized in that the device further includes a button to be pushed in in response to a user's action of clenching his or her fist; the control apparatus further includes a force sense presentation section adapted to present a force sense that resists the pushing in of the button; and in a case where the character performs an action of grasping a target in a virtual space and when an amount of pushing in of the button becomes equivalent to a size of the target, the character control section instructs the force sense presentation section to present a force sense that resists the pushing in of the button.
A panel for a drainage box, the panel comprising: a central portion comprising one or more openings for passage of liquid therethrough; side portions surrounding the central portion ; and at least one connection element on each side portion, each connection element comprising: a receiving portion and a protruding portion , characterized in that the receiving portion is shaped complementary to the protruding portion , such that a second panel having a similar connection element can secure to the first panel by connecting through engaging the respective connection elements , such that the protruding portion of the connection element of the first panel fits into the receiving portion of the connection element of the second panel, and the receiving portion of the connection element of the first panel receives the protruding portion of the connection element of the second panel, and wherein the protruding portion and/or the receiving portion are at least partially tapered between a first face of the panel and a second face of the panel . a central portion comprising one or more openings for passage of liquid therethrough; side portions surrounding the central portion ; and at least one connection element on each side portion, each connection element comprising: a receiving portion and a protruding portion , characterized in that the receiving portion is shaped complementary to the protruding portion , such that a second panel having a similar connection element can secure to the first panel by connecting through engaging the respective connection elements , such that the protruding portion of the connection element of the first panel fits into the receiving portion of the connection element of the second panel, and the receiving portion of the connection element of the first panel receives the protruding portion of the connection element of the second panel, and wherein the protruding portion and/or the receiving portion are at least partially tapered between a first face of the panel and a second face of the panel .
Method for predicting a strength of an ultrasonic weld-joint of a wire-cable , comprising the steps of: providing a sample of a wire-cable containing an organic contaminant ; determining a combined-weight of the wire-cable and the contaminant ; removing the contaminant from a surface of the wire-cable using a solvent ; removing the solvent from the surface of the wire-cable ; determining a weight of the wire-cable ; determining a percentage-by-weight of the contaminant removed from the wire-cable based on a formula [(Mb-Ma)/Mb]*100, wherein Mb is the combined-weight of the wire-cable and the contaminant and Ma is the weight of the wire-cable ; and characterized by determining whether the percentage by weight of the contaminant is less than a predetermined threshold , wherein said threshold correlates to the strength of the ultrasonic weld-joint . providing a sample of a wire-cable containing an organic contaminant ; determining a combined-weight of the wire-cable and the contaminant ; removing the contaminant from a surface of the wire-cable using a solvent ; removing the solvent from the surface of the wire-cable ; determining a weight of the wire-cable ; determining a percentage-by-weight of the contaminant removed from the wire-cable based on a formula [(Mb-Ma)/Mb]*100, wherein Mb is the combined-weight of the wire-cable and the contaminant and Ma is the weight of the wire-cable ; and characterized by determining whether the percentage by weight of the contaminant is less than a predetermined threshold , wherein said threshold correlates to the strength of the ultrasonic weld-joint .
A combination instrument for a vehicle comprising: a mechanical push-button ; a display unit configured to display, in a first state, driving operation indicia and, in response to actuation of the mechanical button , to change to a second state in which selectable functions of the instrument cluster are displayed, the selectable functions including headlamp leveling; and an input unit for selecting one of the functions displayed in the second state, characterised in that in the first state of the combined instrument , only the driving mode information is displayed; and the mechanical button comprises a headlamp leveling control symbol and the display unit is further adapted to preselect the headlamp leveling control function in response to actuation of the button . a mechanical push-button ; a display unit configured to display, in a first state, driving operation indicia and, in response to actuation of the mechanical button , to change to a second state in which selectable functions of the instrument cluster are displayed, the selectable functions including headlamp leveling; and an input unit for selecting one of the functions displayed in the second state, in the first state of the combined instrument , only the driving mode information is displayed; and the mechanical button comprises a headlamp leveling control symbol and the display unit is further adapted to preselect the headlamp leveling control function in response to actuation of the button .
A method of transmitting a wireless message on a medium utilizing carrier sense multiple access, CSMA, comprising: receiving , by a first wireless device, at least a portion of a first wireless message transmitted by a second wireless device , wherein the at least a portion of the first wireless message comprises an indication whether the second wireless device requests that receiving devices defer transmissions during transmission of the first wireless message; determining whether to defer transmission of a second wireless message destined for a third wireless device based, at least in part, on the indication; and transmitting the second wireless message to the third wireless device based on the determining. receiving , by a first wireless device, at least a portion of a first wireless message transmitted by a second wireless device , wherein the at least a portion of the first wireless message comprises an indication whether the second wireless device requests that receiving devices defer transmissions during transmission of the first wireless message; determining whether to defer transmission of a second wireless message destined for a third wireless device based, at least in part, on the indication; and transmitting the second wireless message to the third wireless device based on the determining.
An extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, comprising: a) inert cores; b) a drug layer over the inert cores comprising metoprolol succinate; and c) an extended release layer over the drug layer coated cores, wherein the extended release layer comprises water-soluble polymer, selected from the group consisting of hydroxypropyl methyl cellulose, hydroxyethyl cellulose, polyethylene glycol, poly (ethylene oxide), hydroxypropyl cellulose, carboxymethyl cellulose, xanthan gum, starch, and mixtures thereof; and water-insoluble polymer, selected from the group consisting of cellulose ethers, cellulose esters, polymethacrylic acid esters copolymers, aminoalkyl methacrylate copolymers, copolymers of polyvinyl acetate and polyvinyl pyrrolidone, and mixtures thereof; and is present in an amount of 5% to 30% based on the weight of the drug layer coated cores, wherein the metoprolol succinate is present in an amount of 30% to 70% by the total weight of the dosage form and is bioequivalent to the marketed Toprol-XL ® tablet and wherein the extended-release capsule dosage form is in the form of a sprinkle capsule and the coated discrete units have a particle size from 0.2 mm to 2.5 mm. a) inert cores; b) a drug layer over the inert cores comprising metoprolol succinate; and c) an extended release layer over the drug layer coated cores, wherein the extended release layer comprises water-soluble polymer, selected from the group consisting of hydroxypropyl methyl cellulose, hydroxyethyl cellulose, polyethylene glycol, poly (ethylene oxide), hydroxypropyl cellulose, carboxymethyl cellulose, xanthan gum, starch, and mixtures thereof; and water-insoluble polymer, selected from the group consisting of cellulose ethers, cellulose esters, polymethacrylic acid esters copolymers, aminoalkyl methacrylate copolymers, copolymers of polyvinyl acetate and polyvinyl pyrrolidone, and mixtures thereof; and is present in an amount of 5% to 30% based on the weight of the drug layer coated cores, wherein the metoprolol succinate is present in an amount of 30% to 70% by the total weight of the dosage form and is bioequivalent to the marketed Toprol-XL ® tablet and wherein the extended-release capsule dosage form is in the form of a sprinkle capsule and the coated discrete units have a particle size from 0.2 mm to 2.5 mm.
Incineration plant for solid material having - a combustion chamber in which the solid material is combusted and which is partly delimited by a front ceiling , - a combustion grate with which the solid material and combusted solid material can be conveyed through the combustion chamber , - a primary air supply below the top of the combustion grate , - a first pass arranged above the combustion chamber , the combustion chamber and the first pass forming a transition region between the combustion chamber and the first pass such that a center flow arrangement is embodied, characterized in that a protrusion is embodied in the transition region which extends downwards below the front ceiling . - a combustion chamber in which the solid material is combusted and which is partly delimited by a front ceiling , - a combustion grate with which the solid material and combusted solid material can be conveyed through the combustion chamber , - a primary air supply below the top of the combustion grate , - a first pass arranged above the combustion chamber , the combustion chamber and the first pass forming a transition region between the combustion chamber and the first pass such that a center flow arrangement is embodied,
A generator for an electrosurgical system, the generator configured to deliver pulsed field ablation pulses to electroporate cardiac tissue, the generator comprising: a processor having processing circuitry configured to: load predetermined waveform parameters y i ; load predetermined modeling data x i ; accept entry of a user inputted desired lesion characteristic u i wherein the user inputted desired lesion characteristic u i includes lesion depth, lesion surface area, lesion width, and lesion length.; select at least one waveform parameter y from a first set of at least one waveform parameter, the selecting being based on a statistical significance of the waveform parameter y in determining the user inputted desired lesion characteristic u i , the statistical significance being indicated from experimental modelling; and determine at least one pulsed field ablation waveform parameter corresponding to the selected at least one waveform parameter y, based on u i , y i ; and x i said at least one corresponding pulsed field ablation waveform parameter comprising at least one from the group consisting of an applied voltage amplitude and an applied electric field of the pulsed field ablation waveform. load predetermined waveform parameters y i ; load predetermined modeling data x i ; accept entry of a user inputted desired lesion characteristic u i wherein the user inputted desired lesion characteristic u i includes lesion depth, lesion surface area, lesion width, and lesion length.; select at least one waveform parameter y from a first set of at least one waveform parameter, the selecting being based on a statistical significance of the waveform parameter y in determining the user inputted desired lesion characteristic u i , the statistical significance being indicated from experimental modelling; and determine at least one pulsed field ablation waveform parameter corresponding to the selected at least one waveform parameter y, based on u i , y i ; and x i said at least one corresponding pulsed field ablation waveform parameter comprising at least one from the group consisting of an applied voltage amplitude and an applied electric field of the pulsed field ablation waveform.
A system for processing emergency call data comprising: a frame buffer configured to store data frames received from a central emergency call system, each data frame comprising call data associated with an emergency call being handled at one of a plurality of remote emergency call handling systems connected to the central emergency call system; a frame handler configured to: receive a data frame from the frame buffer; identify the remote emergency call handling system handling the emergency call associated with the call data based on a network address in the data frame; extract the call data from the data frame; and generate an output packet comprising a packet body, the packet body comprising the call data, and a packet header, the packet header indicating a data gateway profile associated with the identified remote emergency call handling system; and an output configured to provide the output packet to a data gateway , the data gateway comprising a plurality of data gateway profiles (380a-380N) corresponding to the plurality of remote emergency call handling systems. a frame buffer configured to store data frames received from a central emergency call system, each data frame comprising call data associated with an emergency call being handled at one of a plurality of remote emergency call handling systems connected to the central emergency call system; a frame handler configured to: receive a data frame from the frame buffer; identify the remote emergency call handling system handling the emergency call associated with the call data based on a network address in the data frame; extract the call data from the data frame; and generate an output packet comprising a packet body, the packet body comprising the call data, and a packet header, the packet header indicating a data gateway profile associated with the identified remote emergency call handling system; and receive a data frame from the frame buffer; identify the remote emergency call handling system handling the emergency call associated with the call data based on a network address in the data frame; extract the call data from the data frame; and generate an output packet comprising a packet body, the packet body comprising the call data, and a packet header, the packet header indicating a data gateway profile associated with the identified remote emergency call handling system; and an output configured to provide the output packet to a data gateway , the data gateway comprising a plurality of data gateway profiles (380a-380N) corresponding to the plurality of remote emergency call handling systems.
An abuse-deterrent formulation, comprising medicament, poloxamer, water-soluble anionic polysaccharide, and PEG ester; wherein: the medicament is or a pharmaceutically acceptable salt thereof; the poloxamer is poloxamer 124, the water-soluble anionic polysaccharide is gellan gum, and the PEG ester is polyoxyl stearate; wherein the weight ratio of poloxamer 124:gellan gum:polyoxyl stearate is about 40:30:30; and wherein the formulation comprises 10 mg to 50 mg of medicament. the medicament is or a pharmaceutically acceptable salt thereof; the poloxamer is poloxamer 124, the water-soluble anionic polysaccharide is gellan gum, and the PEG ester is polyoxyl stearate; wherein the weight ratio of poloxamer 124:gellan gum:polyoxyl stearate is about 40:30:30; and wherein the formulation comprises 10 mg to 50 mg of medicament.